Actively Recruiting
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
Led by University Hospital, Bonn · Updated on 2021-10-05
400
Participants Needed
3
Research Sites
452 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Bonn
Lead Sponsor
U
University of Roma La Sapienza
Collaborating Sponsor
AI-Summary
What this Trial Is About
The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.
CONDITIONS
Official Title
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Liver cirrhosis of any cause
- Availability of a CT scan
You will not qualify if you...
- Diagnosis of hepatocellular carcinoma (HCC) or any malignant disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital Bonn
Bonn, Germany
Actively Recruiting
2
University of Frankfurt
Frankfurt, Germany
Actively Recruiting
3
Sapienza University of Rome
Roma, Italy
Actively Recruiting
Research Team
M
Michael Praktiknjo, MD
CONTACT
J
Johannes Chang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here